🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib study evaluates the safety and efficacy of OH2 in combination...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2020-12-01
Trial ID
NCT04616443
Treatments Being Tested
This phase Ib/II study evaluates the safety and efficacy of OH2 in patients...
Status
Terminated
Location
Chongqing University Cancer Hospital
Start Date
2021-02-02
Trial ID
NCT04637698
Treatments Being Tested
To evaluate the efficacy of OH2 injection in patients with unresectable or ...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2023-03-08
Trial ID
NCT05868707
Treatments Being Tested
This is a prospective, multicenter, open, randomized controlled Phase II cl...
Status
Terminated
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-10-17
Trial ID
NCT05648006
Treatments Being Tested
An open-label dose-escalation phase I clinical study to evaluate the safety...
Status
Recruiting
Location
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Start Date
2023-05-05
Trial ID
NCT05698459
Treatments Being Tested
BS008-001 is a multicenter, open-label phase Ib /II trial in heavily pre-tr...
Status
Recruiting
Location
Zhongnan Hospital of Wuhan University
Start Date
2023-09-07
Trial ID
NCT07382531
Treatments Being Tested
Malignant melanoma, is a kind of malignant tumor derived from melanocytes. ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT05068453
Malignant melanoma, is a kind of malignant tumor derived from melanocytes. ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT05070221
This phase I study evaluates the safety and efficacy of OH2 as single agent...
Status
Completed
Location
Peking University Cancer Hospital
Start Date
2018-11-22
Trial ID
NCT04386967
Treatments Being Tested
This phase Ⅰb/Ⅱ study evaluates the safety and efficacy of OH2 for adjuvant...
Status
Recruiting
Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2022-07-11
Trial ID
NCT05232136
Treatments Being Tested